117 related articles for article (PubMed ID: 2525580)
1. Effects of glucocorticoids on the regulation of the hypothalamic-pituitary-somatotropic system in depression.
Rupprecht R; Rupprecht C; Rupprecht M; Noder M; Lesch KP; Mössner J
J Affect Disord; 1989; 17(1):9-16. PubMed ID: 2525580
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor I in depressed patients and controls.
Lesch KP; Rupprecht R; Müller U; Pfüller H; Beckmann H
Acta Psychiatr Scand; 1988 Dec; 78(6):684-8. PubMed ID: 3223325
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone (GH) and prolactin responses after GH-releasing hormone in major depressive disorder: relationship to somatomedin C levels and dexamethasone suppressibility of cortisol.
Lesch KP; Laux G; Erb A; Pfüller H; Beckmann H
Psychoneuroendocrinology; 1988; 13(3):255-63. PubMed ID: 3136488
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
Owashi T; Otsubo T; Oshima A; Nakagome K; Higuchi T; Kamijima K
Psychoneuroendocrinology; 2008 Feb; 33(2):152-61. PubMed ID: 18068306
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-I (IGF-I) plasma concentrations are increased in depressed patients.
Deuschle M; Blum WF; Strasburger CJ; Schweiger U; Weber B; Körner A; Standhardt H; Gotthardt U; Schmider J; Pflaum CD; Heuser I
Psychoneuroendocrinology; 1997 Oct; 22(7):493-503. PubMed ID: 9373883
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic function and the cortisol response to dexamethasone in psychotic depression.
Duval F; Mokrani MC; Crocq MA; Bailey PE; Diep TS; Correa H; Macher JP
Prog Neuropsychopharmacol Biol Psychiatry; 2000 Feb; 24(2):207-25. PubMed ID: 10800744
[TBL] [Abstract][Full Text] [Related]
7. Suppressive effects of dexamethasone on hypothalamic-pituitary-thyroid axis function in depressed patients.
Maes M; Vandewoude M; Schotte C; Martin M; Blockx P
J Affect Disord; 1990 Sep; 20(1):55-61. PubMed ID: 2147190
[TBL] [Abstract][Full Text] [Related]
8. Endocrine responses to growth hormone-releasing hormone, thyrotropin-releasing hormone and corticotropin-releasing hormone in depression.
Lesch KP; Müller U; Rupprecht R; Kruse K; Schulte HM
Acta Psychiatr Scand; 1989 Jun; 79(6):597-602. PubMed ID: 2548370
[TBL] [Abstract][Full Text] [Related]
9. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
[TBL] [Abstract][Full Text] [Related]
10. Determination of the temporal relationship between porcine growth hormone, serum IGF-1 and cortisol concentrations in pigs.
Sillence MN; Etherton TD
J Anim Sci; 1987 Apr; 64(4):1019-23. PubMed ID: 3571017
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone response to clonidine and the cortisol response to dexamethasone in depressive patients.
Valdivieso S; Duval F; Mokrani MC; Schaltenbrand N; Castro JO; Crocq MA; Macher JP
Psychiatry Res; 1996 Feb; 60(1):23-32. PubMed ID: 8852865
[TBL] [Abstract][Full Text] [Related]
12. Pituitary-adrenal axis rhythm disturbances in psychiatric depression.
Pfohl B; Sherman B; Schlechte J; Stone R
Arch Gen Psychiatry; 1985 Sep; 42(9):897-903. PubMed ID: 2994590
[TBL] [Abstract][Full Text] [Related]
13. Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers.
Sher L; Oquendo MA; Burke AK; Cooper TB; Mann JJ
J Affect Disord; 2013 Dec; 151(3):1108-12. PubMed ID: 23866302
[TBL] [Abstract][Full Text] [Related]
14. Noradrenergic function and the cortisol response to dexamethasone in depression.
Rubin AL; Price LH; Charney DS; Heninger GR
Psychiatry Res; 1985 May; 15(1):5-15. PubMed ID: 2989963
[TBL] [Abstract][Full Text] [Related]
15. The relationships between the cortisol responses to dexamethasone and to L-5-HTP, and the availability of L-tryptophan in depressed females.
Maes M; Vandewoude M; Schotte C; Maes L; Martin M; Scharpe S; Blockx P
Biol Psychiatry; 1990 Mar; 27(6):601-8. PubMed ID: 2322619
[TBL] [Abstract][Full Text] [Related]
16. Plasma ACTH and cortisol concentrations before and after dexamethasone.
Kalin NH; Weiler SJ; Shelton SE
Psychiatry Res; 1982 Aug; 7(1):87-92. PubMed ID: 6291080
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone (GH) responses to GH-releasing hormone in depression: correlation with GH release following clonidine.
Lesch KP; Laux G; Erb A; Pfüller H; Beckmann H
Psychiatry Res; 1988 Sep; 25(3):301-10. PubMed ID: 3141943
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine aspects of primary endogenous depression. II. Serum dexamethasone concentrations and hypothalamic-pituitary-adrenal cortical activity as determinants of the dexamethasone suppression test response.
Poland RE; Rubin RT; Lesser IM; Lane LA; Hart PJ
Arch Gen Psychiatry; 1987 Sep; 44(9):790-5. PubMed ID: 3632252
[TBL] [Abstract][Full Text] [Related]
19. Hormonal differences between psychotic and non-psychotic melancholic depression.
Contreras F; Menchon JM; Urretavizcaya M; Navarro MA; Vallejo J; Parker G
J Affect Disord; 2007 Jun; 100(1-3):65-73. PubMed ID: 17098292
[TBL] [Abstract][Full Text] [Related]
20. Hormonal Dynamics Effect of Serum Insulin-Like Growth Factor I and Cortisol/Dehydroepiandrosterone Sulfate Ratio on Symptom Severity of Major Depressive Disorder.
Tajiri M; Suzuki Y; Tsuneyama N; Arinami H; Someya T
J Clin Psychopharmacol; 2019; 39(4):367-371. PubMed ID: 31211752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
